Novel Ingredient Services welcomes Dr Luke Bucci as VP of Product Innovation
Luke R. Bucci, PhD, CCN, CNS has joined Novel Ingredient Services as Vice President of Product Innovation.
Dr Bucci is credited as being one of the key parties responsible for creating the mass market’s joint health category by introducing glucosamine-chondroitin combination products in 1991, said NIS.
"Luke Bucci is one of our industry’s luminaries," said Bob Green, Novel chairman. "With his leadership and expertise, Novel will be able to bring to market even more ingredients that offer innovation, efficacy, and cost-efficiency; develop new technologies; and provide our customers with greater insight into ingredient research."
His wide-ranging expertise includes new ingredient/product assessment and development, as well as designing research that meets manufacturers’ quality, safety, and efficacy specifications. In his new position, Dr. Bucci will be identifying, developing, and refining novel ingredients, as well as heading the company’s scientific clinical research endeavors. He reports to Novel president Peter Bradley.
Prior to joining Novel, Dr. Bucci was Senior Vice President, Research & Scientific Affairs at Renew Life Formulas in Palm Harbor, Fla. Previously, he spent 17 years at Reckitt Benckiser, formerly Schiff Nutrition International, in Salt Lake City, Utah, where he served as Vice President, Research, and as Research & Scientific Affairs Specialist.
